My team at BSRI, and collaborators
in the REDS programs (the American Red Cross and globally), have responded to numerous blood safety threats with rigorous studies
in multiple countries to verify and quantify rates of infected donations, and consequent risks of transmission to and disease outcomes
in recipients.